Oligonucleotide Synthesis Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Oligonucleotide Synthesis Market
1.1. Definition and Scope
1.1.1. Definition of Oligonucleotide Synthesis
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Oligonucleotide Synthesis Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Oligonucleotide Synthesis Market By Product
1.2.3. Oligonucleotide Synthesis Market By Application
1.2.4. Oligonucleotide Synthesis Market By End User
1.2.5. Oligonucleotide Synthesis Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Oligonucleotide Synthesis Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Oligonucleotide Synthesis Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Oligonucleotide Synthesis Market By Product
5.1. Introduction
5.2. Oligonucleotide Synthesis Revenue By Product
5.2.1. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Oligonucleotide-based drugs
5.2.2.1. Oligonucleotide-based Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Synthesized oligonucleotides
5.2.3.1. Synthesized Oligonucleotides Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Reagents
5.2.4.1. Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Equipment
5.2.5.1. Equipment Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Oligonucleotide Synthesis Market By Application
6.1. Introduction
6.2. Oligonucleotide Synthesis Revenue By Application
6.2.1. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast, By Application, 2020-2032
6.2.2. Research
6.2.2.1. Research Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Diagnostics
6.2.3.1. Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Therapeutics
6.2.4.1. Therapeutics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Oligonucleotide Synthesis Market By End User
7.1. Introduction
7.2. Oligonucleotide Synthesis Revenue By End User
7.2.1. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast, By End User, 2020-2032
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Pharmaceutical & biotechnology companies
7.2.3.1. Pharmaceutical & biotechnology companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Diagnostic laboratories
7.2.4.1. Diagnostic laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. CROs and CMOs
7.2.5.1. CROs and CMOs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Academic research institutes
7.2.6.1. Academic research institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Oligonucleotide Synthesis Market By Country
8.1. North America Oligonucleotide Synthesis Market Overview
8.2. U.S.
8.2.1. U.S. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.2. U.S. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.3. U.S. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.3. Canada
8.3.1. Canada Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.2. Canada Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.3. Canada Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Oligonucleotide Synthesis Market By Country
9.1. Europe Oligonucleotide Synthesis Market Overview
9.2. U.K.
9.2.1. U.K. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.K. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.3. U.K. Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.3. Germany
9.3.1. Germany Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Germany Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.3. Germany Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.4. France
9.4.1. France Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4.2. France Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.3. France Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.5. Spain
9.5.1. Spain Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5.2. Spain Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.3. Spain Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.2. Rest of Europe Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Oligonucleotide Synthesis Market By Country
10.1. Asia Pacific Oligonucleotide Synthesis Market Overview
10.2. China
10.2.1. China Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. China Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.3. China Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.3. Japan
10.3.1. Japan Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Japan Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.3. Japan Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.4. India
10.4.1. India Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. India Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.3. India Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.5. Australia
10.5.1. Australia Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Australia Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.3. Australia Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.6. South Korea
10.6.1. South Korea Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. South Korea Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.3. South Korea Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
10.7.2. Rest of Asia-Pacific Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Oligonucleotide Synthesis Market By Country
11.1. Latin AmericaOligonucleotide Synthesis Market Overview
11.2. Brazil
11.2.1. Brazil Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. Brazil Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.3. Brazil Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
11.3. Mexico
11.3.1. Mexico Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Mexico Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.3. Mexico Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. Rest of Latin America Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Oligonucleotide Synthesis Market By Country
12.1. Middle East & Africa Oligonucleotide Synthesis Market Overview
12.2. GCC
12.2.1. GCC Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. GCC Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.3. GCC Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
12.3. South Africa
12.3.1. South Africa Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. South Africa Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.3. South Africa Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Middle East & Africa Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Oligonucleotide Synthesis Revenue (USD Billion) and Forecast By End User, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Oligonucleotide Synthesis Market
13.1. Oligonucleotide Synthesis Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Oligonucleotide Synthesis Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 14. Company Profile
14.1. Thermo Fisher Scientific Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Thermo Fisher Scientific Inc. 2022 Oligonucleotide Synthesis Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Integrated DNA Technologies (IDT)
14.3. Eurofins Genomics
14.4. GenScript Biotech Corporation
14.5. LGC Biosearch Technologies
14.6. BioAutomation Corporation
14.7. Agilent Technologies
14.8. TriLinkBioTechnologies
14.9. GeneDesign, Inc.
14.10. Biosearch Technologies, Inc.
14.11. ATDBio Ltd.
14.12. Sigma-Aldrich Corporation
Frequently Asked Questions
What was the market size of the global oligonucleotide synthesis in 2022?
The market size of oligonucleotide synthesis was USD 7.4 Billion in 2022.
What is the CAGR of the global oligonucleotide synthesis market from 2023 to 2032?
The CAGR of oligonucleotide synthesis is 13.3% during the analysis period of 2023 to 2032.
Which are the key players in the oligonucleotide synthesis market?
The key players operating in the global market are including Thermo Fisher Scientific Inc., Integrated DNA Technologies (IDT), Eurofins Genomics, GenScript Biotech Corporation, LGC Biosearch Technologies, BioAutomation Corporation, Agilent Technologies, TriLinkBioTechnologies, GeneDesign, Inc., Biosearch Technologies, Inc., ATDBio Ltd., and Sigma-Aldrich Corporation.
Which region dominated the global oligonucleotide synthesis market share?
North America held the dominating position in oligonucleotide synthesis industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of oligonucleotide synthesis during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global oligonucleotide synthesis industry?
The current trends and dynamics in the oligonucleotide synthesis industry include increasing demand for DNA sequencing applications, growing research in epigenetics and non-coding RNAs, and expansion of biopharmaceutical R&D activities.
Which application held the maximum share in 2022?
The therapeutics application held the maximum share of the oligonucleotide synthesis industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
